Lloyd Sanders

Chief Executive Officer at Epic Sciences, Inc.

Health Technology

Profile

Lloyd Sanders is currently the President, Chief Executive Officer & Director at Epic Sciences, Inc. He previously worked as the Chief Operating Officer at Mylan Specialty LP.

Lloyd Sanders active positions

Companies	Position	Start
Epic Sciences, Inc. Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA.	Chief Executive Officer	24/03/2019

All active positions of Lloyd Sanders

Former positions of Lloyd Sanders

Companies	Position	End
Mylan Specialty LP Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV.	Chief Operating Officer	-

See the detail of Lloyd Sanders's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lloyd Sanders's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Mylan Specialty LP Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV.	Health Technology
Epic Sciences, Inc. Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA.	Health Technology